CLPT (ClearPoint Neuro) E10: $-1.03 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPT ClearPoint Neuro Inc CLPT
63 GF Score
Price $14.63
GF Value $14.14
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is ClearPoint Neuro E10?

ClearPoint Neuro CLPT -1.75% 63 E10 is $-1.03 as of Jun. 2026. GuruFocus rates CLPT with a GF Score™ of 63/100 and a GF Value™ of $14.14 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ClearPoint Neuro's adjusted earnings per share data for the three months ended in Jun. 2026 was $-0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.03 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ClearPoint Neuro was 21.40% per year. The lowest was 17.10% per year. And the median was 19.25% per year.

As of today (2026-08-12), ClearPoint Neuro's current stock price is $14.63. ClearPoint Neuro's E10 for the quarter that ended in Jun. 2026 was $-1.03. ClearPoint Neuro's Shiller PE Ratio of today is .


ClearPoint Neuro  (NAS:CLPT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ClearPoint Neuro E10 Related Terms


ClearPoint Neuro E10 Historical Data

* Premium members only.

The historical data trend for ClearPoint Neuro's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ClearPoint Neuro E10 Chart

ClearPoint Neuro Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.91 -2.41 -1.96 -1.66 -1.17

ClearPoint Neuro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.24 -1.26 -1.17 -1.10 -1.03

CLPT vs SI, PACB, DCTH: E10 Comparison

For the Medical Devices subindustry, ClearPoint Neuro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClearPoint Neuro Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ClearPoint Neuro's Shiller PE Ratio falls into.


CLPT
63GF Score
ClearPoint Neuro Inc CLPT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ClearPoint Neuro E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ClearPoint Neuro's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.38/333.9520*333.9520
=-0.380

Current CPI (Jun. 2026) = 333.9520.

ClearPoint Neuro Quarterly Data

per share eps CPI Adj_EPS
201609 -0.920 241.428 -1.273
201612 -0.470 241.432 -0.650
201703 -0.460 243.801 -0.630
201706 -0.320 244.955 -0.436
201709 -0.140 246.819 -0.189
201712 -0.200 246.524 -0.271
201803 -0.150 249.554 -0.201
201806 -0.170 251.989 -0.225
201809 -0.130 252.439 -0.172
201812 -0.110 251.233 -0.146
201903 -0.110 254.202 -0.145
201906 -0.130 256.143 -0.169
201909 -0.080 256.759 -0.104
201912 -0.110 256.974 -0.143
202003 -0.130 258.115 -0.168
202006 -0.110 257.797 -0.142
202009 -0.090 260.280 -0.115
202012 -0.090 260.474 -0.115
202103 -0.130 264.877 -0.164
202106 -0.170 271.696 -0.209
202109 -0.180 274.310 -0.219
202112 -0.190 278.802 -0.228
202203 -0.170 287.504 -0.197
202206 -0.180 296.311 -0.203
202209 -0.150 296.808 -0.169
202212 -0.180 296.797 -0.203
202303 -0.230 301.836 -0.254
202306 -0.290 305.109 -0.317
202309 -0.200 307.789 -0.217
202312 -0.190 306.746 -0.207
202403 -0.160 312.332 -0.171
202406 -0.160 314.175 -0.170
202409 -0.180 315.301 -0.191
202412 -0.200 315.605 -0.212
202503 -0.220 319.799 -0.230
202506 -0.210 322.561 -0.217
202509 -0.210 324.800 -0.216
202512 -0.270 324.054 -0.278
202603 -0.320 330.213 -0.324
202606 -0.380 333.952 -0.380

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.03 mean?
ClearPoint Neuro (CLPT) has a E10 of $-1.03 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ClearPoint Neuro and its competitors.
Is ClearPoint Neuro's E10 too high?
ClearPoint Neuro's current E10 is $-1.03. Overall, ClearPoint Neuro has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ClearPoint Neuro's E10 compare to SI and PACB?
ClearPoint Neuro's E10 of $-1.03 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ClearPoint Neuro and its competitors. ClearPoint Neuro's current E10 is $-1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClearPoint Neuro stock overvalued right now?
Based on GuruFocus' analysis, ClearPoint Neuro (CLPT) is currently considered Fairly Valued. The stock's GF Value™ is $14.14, compared to a current price of $14.63 — trading 3.5% above its estimated fair value. The current E10 is $-1.03. ClearPoint Neuro's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For ClearPoint Neuro (CLPT), the current E10 is $-1.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ClearPoint Neuro (CLPT) Overvalued in 2026?

Based on GuruFocus' analysis, ClearPoint Neuro stock appears to be overvalued. The current stock price of $14.63 is trading 3.5% above its estimated GF Value™ of $14.14. GuruFocus considers ClearPoint Neuro to be Fairly Valued.

Key valuation signals for CLPT:

  • E10: $-1.03
  • GF Value™: $14.14 vs. price of $14.63 (3.5% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the CLPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ClearPoint Neuro Business Description

Address 120 S. Sierra Avenue, Suite 100, Solana Beach, CA, USA, 92075
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
63GF Score

Get the complete analysis for CLPT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.63
Price
$14.14
GF Value